Drug Shortage Report for MEROPENEM FOR INJECTION
Report ID | 113123 |
Drug Identification Number | 02462893 |
Brand name | MEROPENEM FOR INJECTION |
Common or Proper name | Meropenem |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MEROPENEM |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | box of 10 vials |
ATC code | J01DH |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-04-23 |
Estimated end date | |
Actual end date | 2020-07-07 |
Shortage status | Resolved |
Updated date | 2020-07-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-07-08 | English | Compare |
v6 | 2020-07-07 | French | Compare |
v5 | 2020-07-07 | English | Compare |
v4 | 2020-07-06 | French | Compare |
v3 | 2020-07-06 | English | Compare |
v2 | 2020-04-24 | French | Compare |
v1 | 2020-04-24 | English | Compare |
Showing 1 to 7 of 7